1. Home
  2. HUBCW vs CMMB Comparison

HUBCW vs CMMB Comparison

Compare HUBCW & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBCW
  • CMMB
  • Stock Information
  • Founded
  • HUBCW N/A
  • CMMB 2004
  • Country
  • HUBCW Israel
  • CMMB Israel
  • Employees
  • HUBCW 223
  • CMMB N/A
  • Industry
  • HUBCW
  • CMMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUBCW
  • CMMB Health Care
  • Exchange
  • HUBCW Nasdaq
  • CMMB Nasdaq
  • Market Cap
  • HUBCW N/A
  • CMMB 37.3M
  • IPO Year
  • HUBCW N/A
  • CMMB N/A
  • Fundamental
  • Price
  • HUBCW $0.04
  • CMMB $2.01
  • Analyst Decision
  • HUBCW
  • CMMB Strong Buy
  • Analyst Count
  • HUBCW 0
  • CMMB 2
  • Target Price
  • HUBCW N/A
  • CMMB $7.50
  • AVG Volume (30 Days)
  • HUBCW N/A
  • CMMB 81.9K
  • Earning Date
  • HUBCW N/A
  • CMMB 03-06-2025
  • Dividend Yield
  • HUBCW N/A
  • CMMB N/A
  • EPS Growth
  • HUBCW N/A
  • CMMB N/A
  • EPS
  • HUBCW N/A
  • CMMB N/A
  • Revenue
  • HUBCW N/A
  • CMMB N/A
  • Revenue This Year
  • HUBCW N/A
  • CMMB N/A
  • Revenue Next Year
  • HUBCW N/A
  • CMMB N/A
  • P/E Ratio
  • HUBCW N/A
  • CMMB N/A
  • Revenue Growth
  • HUBCW N/A
  • CMMB N/A
  • 52 Week Low
  • HUBCW N/A
  • CMMB $0.55
  • 52 Week High
  • HUBCW N/A
  • CMMB $2.55
  • Technical
  • Relative Strength Index (RSI)
  • HUBCW N/A
  • CMMB 49.85
  • Support Level
  • HUBCW N/A
  • CMMB $1.86
  • Resistance Level
  • HUBCW N/A
  • CMMB $2.15
  • Average True Range (ATR)
  • HUBCW 0.00
  • CMMB 0.14
  • MACD
  • HUBCW 0.00
  • CMMB -0.02
  • Stochastic Oscillator
  • HUBCW 0.00
  • CMMB 45.45

About HUBCW Hub Cyber Security Ltd. Warrant 2/27/28

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Share on Social Networks: